[{"address1": "301 Binney Street", "address2": "3rd Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 259 3860", "website": "https://scholarrock.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Jay Thomas Backstrom M.D., M.P.H.", "age": 68, "title": "President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 1071673, "exercisedValue": 0, "unexercisedValue": 3439375}, {"maxAge": 1, "name": "Mr. Edward H. Myles MBA", "age": 52, "title": "CFO, COO & Treasurer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 720786, "exercisedValue": 0, "unexercisedValue": 857292}, {"maxAge": 1, "name": "Ms. Tracey M. Sacco M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 548855, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mo  Qatanani Ph.D.", "age": 51, "title": "Chief Scientific Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rushmie  Nofsinger", "title": "Vice President of Corporate Affairs & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Junlin  Ho J.D.", "age": 45, "title": "General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 563729, "exercisedValue": 0, "unexercisedValue": 112564}, {"maxAge": 1, "name": "Ms. Caryn  Parlavecchio", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa Amaya Price", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Moore CPA", "age": 49, "title": "Senior Vice President of Finance", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Iarrobino", "title": "Senior Vice President of Clinical Development & Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 35.96, "open": 35.72, "dayLow": 35.37, "dayHigh": 39.17, "regularMarketPreviousClose": 35.96, "regularMarketOpen": 35.72, "regularMarketDayLow": 35.37, "regularMarketDayHigh": 39.17, "payoutRatio": 0.0, "beta": 0.508, "forwardPE": -18.055813, "volume": 1101691, "regularMarketVolume": 1101691, "averageVolume": 918688, "averageVolume10days": 681740, "averageDailyVolume10Day": 681740, "bid": 38.7, "ask": 46.29, "bidSize": 5, "askSize": 2, "marketCap": 3675353344, "fiftyTwoWeekLow": 6.76, "fiftyTwoWeekHigh": 46.98, "fiftyDayAverage": 41.3785, "twoHundredDayAverage": 22.706276, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3256206336, "profitMargins": 0.0, "floatShares": 78031806, "sharesOutstanding": 94676800, "sharesShort": 15982742, "sharesShortPriorMonth": 15655815, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1707, "heldPercentInsiders": 0.010829999, "heldPercentInstitutions": 1.16616, "shortRatio": 17.41, "shortPercentOfFloat": 0.316, "impliedSharesOutstanding": 93615000, "bookValue": 4.603, "priceToBook": 8.43363, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -246294000, "trailingEps": -2.47, "forwardEps": -2.15, "enterpriseToEbitda": -13.025, "52WeekChange": 1.3411458, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 38.82, "targetHighPrice": 57.0, "targetLowPrice": 39.0, "targetMeanPrice": 49.375, "targetMedianPrice": 50.0, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 437278016, "totalCashPerShare": 4.671, "ebitda": -249998000, "totalDebt": 59352000, "quickRatio": 9.316, "currentRatio": 9.612, "debtToEquity": 16.101, "returnOnAssets": -0.40087003, "returnOnEquity": -0.82948, "grossProfits": -184550000, "freeCashflow": -143909744, "operatingCashflow": -200948992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SRRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -2.47, "epsForward": -2.15, "epsCurrentYear": -2.21451, "priceEpsCurrentYear": -17.529837, "fiftyDayAverageChange": -2.5585022, "fiftyDayAverageChangePercent": -0.06183168, "twoHundredDayAverageChange": 16.113724, "twoHundredDayAverageChangePercent": 0.70965946, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1527255000000, "regularMarketChangePercent": 7.9532833, "regularMarketPrice": 38.82, "exchange": "NMS", "messageBoardId": "finmb_548810128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "corporateActions": [], "postMarketTime": 1740779714, "regularMarketTime": 1740776401, "marketState": "CLOSED", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 0.0, "shortName": "Scholar Rock Holding Corporatio", "longName": "Scholar Rock Holding Corporation", "postMarketPrice": 38.82, "postMarketChange": 0.0, "regularMarketChange": 2.8600006, "regularMarketDayRange": "35.37 - 39.17", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 918688, "fiftyTwoWeekLowChange": 32.059998, "fiftyTwoWeekLowChangePercent": 4.742603, "fiftyTwoWeekRange": "6.76 - 46.98", "fiftyTwoWeekHighChange": -8.16, "fiftyTwoWeekHighChangePercent": -0.17369093, "fiftyTwoWeekChangePercent": 134.11458, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1740662100, "earningsCallTimestampEnd": 1740662100, "isEarningsDateEstimate": true, "displayName": "Scholar Rock Holding", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]